Design Therapeutics (DSGN) Share-based Compensation: 2020-2024
Historic Share-based Compensation for Design Therapeutics (DSGN) over the last 5 years, with Dec 2024 value amounting to $13.1 million.
- Design Therapeutics' Share-based Compensation rose 269.60% to $1.6 million in Q4 2021 from the same period last year, while for Dec 2021 it was $4.7 million, marking a year-over-year increase of 942.00%. This contributed to the annual value of $13.1 million for FY2024, which is 0.12% down from last year.
- Design Therapeutics' Share-based Compensation amounted to $13.1 million in FY2024, which was down 0.12% from $13.1 million recorded in FY2023.
- In the past 5 years, Design Therapeutics' Share-based Compensation registered a high of $13.1 million during FY2023, and its lowest value of $450,000 during FY2020.
- For the 3-year period, Design Therapeutics' Share-based Compensation averaged around $12.4 million, with its median value being $13.1 million (2024).
- As far as peak fluctuations go, Design Therapeutics' Share-based Compensation surged by 942.00% in 2021, and later fell by 0.12% in 2024.
- Yearly analysis of 5 years shows Design Therapeutics' Share-based Compensation stood at $450,000 in 2020, then spiked by 942.00% to $4.7 million in 2021, then soared by 132.99% to $10.9 million in 2022, then grew by 19.80% to $13.1 million in 2023, then declined by 0.12% to $13.1 million in 2024.